Secretary confirms phased removal of harmful food dyes and fast-tracked substitutes

The U.S. House Committee on Appropriations convened on May 16, 2025, for a budget hearing focused on the U.S. Department of Health and Human Services (HHS). The meeting addressed several key issues, including food safety, drug pricing, and mental health resources.

The session began with discussions on food dyes, particularly their safety and the potential health risks associated with certain artificial colors. A committee member expressed concerns about the link between these dyes and health issues such as ADHD and cancer. The HHS Secretary confirmed that the department has been collaborating with the food industry to phase out the two most harmful dyes—orange B and red 40—within two months, with plans to eliminate seven additional dyes within two years. The Secretary noted that some companies, like Tyson Foods, have already begun this transition. Additionally, three vegetable dye substitutes have been fast-tracked and approved for use.

The conversation then shifted to the 340B drug discount program, which provides essential funding to safety net hospitals and community health centers. A committee member inquired about the potential transfer of oversight from the Health Resources and Services Administration (HRSA) to the Centers for Medicare & Medicaid Services (CMS). The Secretary acknowledged the program's complexity and its critical role in supporting rural hospitals, emphasizing the need for careful management to avoid jeopardizing these institutions.

Further discussions included the administration's approach to chronic diseases and the promotion of healthier diets, with a focus on reducing ultra-processed foods and junk chemicals. The Secretary affirmed the commitment to improving access to non-pharmaceutical remedies as part of healthcare decisions.

The topic of mental health resources was also raised, particularly regarding the 988 hotline for suicide prevention. A committee member expressed concern over the removal of a specific button for LGBTQ+ youth, highlighting the unique risks faced by this demographic. The Secretary expressed willingness to engage in further discussions on this matter, emphasizing the importance of cultural sensitivity in mental health services.

Lastly, the committee addressed Medicare Advantage, with concerns raised about waste and overpayments in the program. The Secretary acknowledged the need to tackle fraud and abuse while recognizing the program's popularity among beneficiaries.

In conclusion, the hearing underscored the HHS's ongoing efforts to address public health concerns, improve healthcare access, and ensure the sustainability of critical programs. The committee members expressed a desire for continued collaboration with the Secretary to navigate these complex issues effectively.